BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2841455)

  • 1. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
    Gee KW; Bolger MB; Brinton RE; Coirini H; McEwen BS
    J Pharmacol Exp Ther; 1988 Aug; 246(2):803-12. PubMed ID: 2841455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurosteroid Modulation of Synaptic and Extrasynaptic GABA
    Mitchell SJ; Phillips GD; Tench B; Li Y; Belelli D; Martin SJ; Swinny JD; Kelly L; Atack JR; Paradowski M; Lambert JJ
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone: Regenerative therapeutic to restore neurological health.
    Hernandez GD; Brinton RD
    Neurobiol Stress; 2022 Nov; 21():100502. PubMed ID: 36532370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma-1 receptors and progesterone metabolizing enzymes in nociceptive sensory neurons of the female rat trigeminal ganglia: A neural substrate for the antinociceptive actions of progesterone.
    Hornung RS; Raut NG; Cantu DJ; Lockhart LM; Averitt DL
    Mol Pain; 2022; 18():17448069211069255. PubMed ID: 35040378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future.
    Manzella FM; Covey DF; Jevtovic-Todorovic V; Todorovic SM
    J Neuroendocrinol; 2022 Feb; 34(2):e13086. PubMed ID: 35014105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regional effect of serum hormone levels on cerebral blood flow in healthy nonpregnant women.
    Cote S; Butler R; Michaud V; Lavallee E; Croteau E; Mendrek A; Lepage JF; Whittingstall K
    Hum Brain Mapp; 2021 Dec; 42(17):5677-5688. PubMed ID: 34480503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.
    Hernandez GD; Solinsky CM; Mack WJ; Kono N; Rodgers KE; Wu CY; Mollo AR; Lopez CM; Pawluczyk S; Bauer G; Matthews D; Shi Y; Law M; Rogawski MA; Schneider LS; Brinton RD
    Alzheimers Dement (N Y); 2020; 6(1):e12107. PubMed ID: 33344752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realising the therapeutic potential of neuroactive steroid modulators of the GABA
    Belelli D; Hogenkamp D; Gee KW; Lambert JJ
    Neurobiol Stress; 2020 May; 12():100207. PubMed ID: 32435660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.
    Nipper MA; Jensen JP; Helms ML; Ford MM; Crabbe JC; Rossi DJ; Finn DA
    Neuroscience; 2019 Jan; 397():127-137. PubMed ID: 30513375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA
    Olsen RW
    Neuropharmacology; 2018 Jul; 136(Pt A):10-22. PubMed ID: 29407219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Fatty Acids Mixture Reduces Anxiety-Like Behaviors in Infant Rats Mediated by GABA
    Bernal-Morales B; Cueto-Escobedo J; Guillén-Ruiz G; Rodríguez-Landa JF; Contreras CM
    Biomed Res Int; 2017; 2017():8798546. PubMed ID: 29392140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol.
    Finn DA; Jimenez VA
    Handb Exp Pharmacol; 2018; 248():55-78. PubMed ID: 29242992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.
    Clossen BL; Reddy DS
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1519-1538. PubMed ID: 28179120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effect of ethanolic extract of Argemone mexicana and its alkaloids in Wistar rats.
    Arcos-Martínez AI; Muñoz-Muñiz OD; Domínguez-Ortiz MÁ; Saavedra-Vélez MV; Vázquez-Hernández M; Alcántara-López MG
    Avicenna J Phytomed; 2016; 6(4):476-88. PubMed ID: 27516989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroids for the potential protection of humans against organophosphate toxicity.
    Reddy DS
    Ann N Y Acad Sci; 2016 Aug; 1378(1):25-32. PubMed ID: 27450921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic δGABA(A) Receptors.
    Carver CM; Reddy DS
    J Pharmacol Exp Ther; 2016 Apr; 357(1):188-204. PubMed ID: 26857959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent treatment advances and novel therapeutic approaches in epilepsy.
    Serrano E; Kanner AM
    F1000Prime Rep; 2015; 7():61. PubMed ID: 26097734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures.
    Bruun DA; Cao Z; Inceoglu B; Vito ST; Austin AT; Hulsizer S; Hammock BD; Tancredi DJ; Rogawski MA; Pessah IN; Lein PJ
    Neuropharmacology; 2015 Aug; 95():332-42. PubMed ID: 25882826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the menstrual cycle on bispectral index and anesthetic requirement in patients with preoperative intravenous dexmedetomidine following propofol induction.
    Zhou X; Wang T; Huang S
    Int J Clin Exp Med; 2014; 7(12):5663-8. PubMed ID: 25664087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
    Irwin RW; Solinsky CM; Brinton RD
    Front Cell Neurosci; 2014; 8():203. PubMed ID: 25126056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.